Source: DGNews | Posted 8 years ago
FDA Approves Abilify (Aripiprazole) Supplemental New Drug Application for Maintaining Stability in Patients With Schizophrenia
Tags:
PRINCETON, NJ and TOKYO, JAPAN -- September 9, 2003 -- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (U.S. FDA) approved a Supplemental New Drug Application (sNDA) for Abilify
Comments